Thank you Gabe. Good morning and welcome to AFC Gamma's earnings call for the quarter ended September 30, 2023. I would like to thank everyone for joining us today to discuss our results. Before turning to the quarterly results, we are very excited and I am personally excited to announce the appointment of Dan Neville, the new Chief Executive Officer of AFC Gamma effective this coming Monday. As Dan joins us in his new role, I will transition from Chairman of the Board and Chief Executive Officer to Executive Chairman of the Board and Chief Investment Officer. Dan joins us from Ascend Wellness Holdings, a leading multi-state vertically integrated cannabis operator where he's held various roles including Interim CEO and most recently as Chief Financial Officer. Dan joined Ascend as one of its first employees and he was instrumental in helping grow the company to an operator with seven states, 2000-plus employees and over $500 million in revenue. Dan's expertise in cannabis operations, M&A activity and deal structuring uniquely positions him to lead AFC Gamma as CEO. We have noticed that as a lend area has become increasingly important to have in-house operating expertise to contribute to the underwriting and portfolio management of cannabis credits. Therefore, Dan's operating and M&A expertise combined with my 25 years of direct lending experience, position AFC Gamma to continue as a leading debt provider in the cannabis industry. We are very excited to have Dan join us as the team and I have worked closely with him on a number of matters when he was at Ascend. For example, we have the opportunity to witness Dan's expertise firsthand as he led Ascend's acquisition of certain assets of two of our portfolio companies. We've also been in frequent communication about the industry and investment opportunities with him over the years. We look forward to working with him to continue building AFC Gamma as we enter the next phase of the cannabis industry. The appointment of Dan as CEO reaffirms, AFC Gamma's commitment to lending to the cannabis industry. As we have discussed on a quarterly basis over the last year we are increasingly seeing cannabis 3.0 operators emerge and we are excited to deploy capital and expand AFC Gamma's platform as operators have a difficult time accessing the capital markets. I believe AFC Gamma is uniquely positioned to capitalize on the opportunity to provide capital to existing borrowers and new well-capitalized operators that are looking to build and/or expand by buying distressed assets or assets at a significant discount. Turning to the quarterly results. For the third quarter of 2023, AFC Gamma generated distributable earnings of $0.49 per basic weighted average share of common stock. As a reminder, distributable earnings is the primary metric that the Board considers when declaring AFC Gamma's quarterly dividend. The Board of Directors declared a $0.48 dividend per share in the September quarter. Since going public, we have generated distributable earnings that have met or exceeded our dividend each quarter and paid out $5.06 in dividends per share. In June of this year, management stated that we anticipated the $0.48 dividend represented a sustainable dividend level on the current portfolio for 2023, assuming no significant nonaccruals and without any additional investments. Despite our investment in private company G being put on nonaccrual for a period of time, we continue to believe that this is true for the remainder of 2023. Since mid-2022, given the volatility in the cannabis market, we became increasingly selective on these new investments and maintained ample cash to capitalize on opportunities that may arise. We are excited about the new opportunities we are seeing, driven by an uptick in acquisition activity, both from existing operators buying distressed assets, as well as new investors coming into the market to purchase assets at a significant discount. The capital formation around these assets is promising and we are focused on well-capitalized operators in attractive states, such as Missouri, Georgia, Maryland, Arizona and Ohio to name a few. Following our thesis during the quarter, we funded a new cannabis investment to private company M of approximately $25 million into one of the newly formed well-capitalized operators that we believe will continue to consolidate valuable assets in key limited license states. We continue to have liquidity to make additional investments in operators in limited license states that we believe have strong risk-adjusted profiles. Additionally, we are pleased to see that the ballot initiative to introduce adult-use in Ohio passed yesterday, which we believe will be a large positive for operators in the state. AFC Gamma has exposure to Ohio through two of our larger credit facilities, including our $84 million commitment to subsidiary of public company each and a $63 million commitment to private company L. We believe both operators should materially benefit from Ohio moving to a recreational model. As we are focused on active portfolio management, two borrowers have been placed into receivership to optimize operations and maximize value for the benefit of the creditors. One of the borrowers, private company A, has been actively liquidating certain assets and has so far paid down over $48 million in principle to AFC Gamma and syndicate partners, of which $27 million was received during the quarter, primarily from the sale of its Maryland and Arizona operations. As we have discussed during the last several quarters, a subsidiary of private company G which we closely -- continue to closely monitor, continues to have cash flow challenges as it completes a valuable construction project in New Jersey. As we stated last quarter, we put a subsidiary of private company G on nonaccrual for the month of June. As we did not receive interest payments in July and August, the bar remained on nonaccrual for those two months. To ensure the borrower has adequate working capital in New Jersey, we have modified interest payments for the remainder of the year. AFC Gamma has received its portion of the $800,000 in cash interest that was due for the month of September and the $1 million of cash interest that was due in the month of October and $1 million in cash interest is due in November and December. As it relates to this loan, we are currently not accruing any interest into income that's not been paid in cash. We continue to remain excited about the near-term prospects in New Jersey and look forward to the full optimization of their cultivation facility. As I previously discussed, we have recently focused on reducing payment in kind interest as a component of our income. During the first quarter of 2023, PIK or Payment-in-Kind as a percentage of income was 25%. But now for the quarter ended September 30, 2023, we have decreased that level to a much more normalized level of 10%. We are pleased about the significant decrease in PIK, which is mainly due to our active management. As we have said in past calls, we believe, there are credible new cannabis operators entering the market that are well capitalized to take advantage of the current market environment. We are also pleased to have Dan join us and look forward to introducing him to our analysts and investors in the coming months. I will now turn the call over to Brandon to review our financial results.